Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Travera Inc
AstraZeneca
Dragonfly Therapeutics
Dana-Farber Cancer Institute
University of Michigan Rogel Cancer Center
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
Institut Bergonié
Cue Biopharma
City of Hope Medical Center
Hospices Civils de Lyon
AstraZeneca
Shanghai Escugen Biotechnology Co., Ltd
Sahlgrenska University Hospital
Washington University School of Medicine
Incyte Corporation
Palleon Pharmaceuticals, Inc.
Incyte Corporation
AstraZeneca
Merck Sharp & Dohme LLC
Novita Pharmaceuticals, Inc.
Incyte Corporation
Institut Bergonié
Celldex Therapeutics
NGM Biopharmaceuticals, Inc
Revolution Medicines, Inc.
Labcorp Corporation of America Holdings, Inc
UNC Lineberger Comprehensive Cancer Center
Stanford University
Lindis Bloodcare GmbH
Taproot Health
Acepodia Biotech, Inc.
Astellas Pharma Inc
Astellas Pharma Inc
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Eli Lilly and Company
Pfizer
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
Stanford University
DxTerity Diagnostics
Arcus Biosciences, Inc.
pharmaand GmbH
Exelixis
Sanguine Biosciences
Celldex Therapeutics
STCube, Inc.
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute